Lack of Association of the MDR1 C3435T Polymorphism with Susceptibility to Gastric Cancer and Peptic Ulcer: a Systemic Review and Meta-analysis |
Wu, Dan-Dan
(Department of Gastroenterology, Renmin Hospital of Wuhan University)
Zhang, Ji-Xiang (Department of Gastroenterology, Renmin Hospital of Wuhan University) Li, Jiao (Department of Gastroenterology, Renmin Hospital of Wuhan University) Dong, Wei-Guo (Department of Gastroenterology, Renmin Hospital of Wuhan University) |
1 | Yuan H, Li X, Wu J, et al (2008). Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance. Curr Med Chem, 15, 470-6. DOI ScienceOn |
2 | Tahara T, Arisawa T, Shibata T, et al (2007). Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. J Gastroenterol Hepatol, 22, 1678-82. DOI ScienceOn |
3 | Wang ZM, Wang T, Bian JN (2013). Association between MDR1 C3435T polymorphism and risk of breast cancer. Gene, 532, 94-9. DOI ScienceOn |
4 | Wu H, Xu C, Chen G, et al (2013). XRCC1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis. J Gastroenterol Hepatol. [Epub ahead of print] |
5 | Zhang D, Wang C, Zhou Z (2013). Meta-Analysis of ABCB1 3435C>T Polymorphism and Colorectal Cancer. Pak J Med Sci, 29, 1269-74. |
6 | Zintzaras E, Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol, 28, 123-37. DOI ScienceOn |
7 | Zou TH, Wang ZH, Fang JY (2013). Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis. Tumour Biol, 34, 2441-50. DOI ScienceOn |
8 | Oliveira J, Felipe AV, Chang PY, et al (2012). Association between the C3435T single-nucleotide polymorphism of multidrug resistance 1 gene and risk of gastric cancer. Mol Med Rep, 6, 395-8. DOI |
9 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
10 | Markova S, Nakamura T, Sakaeda T, et al (2006). Genotype-dependent down-regulation of gene expression and function of MDR1 in human peripheral blood mononuclear cells under acute inflammation. Drug Metab Pharmacokinet, 21, 194-200. DOI ScienceOn |
11 | Mizutani T, Masuda M, Nakai E, et al (2008). Genuine functions of P-glycoprotein (ABCB1). Curr Drug Metab, 9, 167-74. DOI ScienceOn |
12 | Piao Y, Liu Z, Ding Z, et al (2013). EGF +61A>G polymorphism and gastrointestinal cancer risk: A HuGE review and meta-analysis. Gene, 519, 26-33. DOI ScienceOn |
13 | Sabahi Z, Salek R, Heravi RE, et al (2010). Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. Indian J Cancer, 47, 317-21. DOI ScienceOn |
14 | Song B, Duan ZY, Zhong YH, et al (2013). Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk. Asian Pac J Cancer Prev, 14, 6649-51. 과학기술학회마을 DOI ScienceOn |
15 | Sugimoto M, Furuta T, Shirai N, et al (2008). MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese. Life Sci, 83, 301-4. DOI ScienceOn |
16 | Sung JJ, Kuipers EJ, El-Serag HB (2009). Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther, 29, 938-46. DOI ScienceOn |
17 | Tahara T, Shibata T, Yamashita H, et al (2011). Influence of MDR1 polymorphism on H. pylori-related chronic gastritis. Dig Dis Sci, 56, 103-8. DOI |
18 | Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90. DOI |
19 | Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. DOI ScienceOn |
20 | Hoffmeyer S, Burk O, von Richter O, et al (2000). Functional polymorphisms of the human multidrug resistance gene multiple sequence variations and correlation of one allele with p-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA, 97, 3473-8. DOI ScienceOn |
21 | Johnstone RW, Ruefli AA, Smyth MJ (2000). Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem Sci, 25, 1-6. DOI ScienceOn |
22 | Larsen UL, Hyldahl OL, Olesen L, et al (2007). Human intestinal P-glycoprotein activity estimated by the model substrate digoxin. Scand J Clin Lab Invest, 67, 123-34. DOI ScienceOn |
23 | Lauren P (1965). The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand, 64, 31-49. DOI |
24 | Li X, Qu L, Zhong Y, et al (2013). Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis. J Cancer Res Clin Oncol, 139, 1433-47. DOI ScienceOn |
25 | Liu Y, Li L, Qi H, et al (2013). Survivin 231G.C polymorphism and gastrointestinal tract cancer risk: a meta-analysis. PLoS One, 8, 54081. DOI |
26 | Lozano R, Naghavi M, Foreman K, et al (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2095-128. DOI ScienceOn |
27 | Breier A, Barancik M, Sulova Z, et al (2005). P-glycoprotein-implications of metabolism of neoplastic cells and cancer therapy. Curr Cancer Drug Targets, 5, 457-68. DOI ScienceOn |
28 | Annese V, Valvano MR, Palmieri O, et al (2006). Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol, 12, 3636-44. DOI |
29 | Basiri Z, Safaralizadeh R, Bonyadi MJ, et al (2014). Helicobacter pylori vacA d1 genotype predicts risk of gastric adenocarcinoma and peptic ulcers in Northwestern Iran. Asian Pac J Cancer Prev, 15, 1575-9. DOI ScienceOn |
30 | Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. DOI ScienceOn |
31 | Chang H, Rha SY, Jeung HC, et al (2010). Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. Oncol Rep, 23, 271-8. |
32 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI ScienceOn |
33 | Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI ScienceOn |
34 | Ho GT, Moodie FM, Satsangi J (2003). Multidrug resistance 1 gene (p-glycoprotein 170): an important determinant in gastrointestinal disease? Gut, 52, 759-66. DOI |